In a 14-day multiple-dose study the pharmacokinetics of paroxetine was investigated in 12 patients with alcoholic cirrhosis and in 6 subjects without liver disease. The dose of 20-30 mg paroxetine daily was adjusted to the reduction in liver function, as assessed by the galactose elimination capacit
β¦ LIBER β¦
Buspirone pharmacokinetics in patients with cirrhosis.
β Scribed by K Dalhoff; HE Poulsen; P Garred; M Placchi; RE Gammans; RF Mayol; M Pfeffer
- Book ID
- 117944437
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 468 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0306-5251
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Pharmacokinetics of paroxetine in patien
β
K. Dalhoff; T. P. Almdal; K. Bjerrum; S. Keiding; H. Mengel; J. Lund
π
Article
π
1991
π
Springer
π
English
β 419 KB
Pharmacokinetics of lomefloxacin in pati
β
Didier Lebrec; Christophe Gaudin; Jean-Pierre Benhamou
π
Article
π
1992
π
Elsevier Science
π
English
β 309 KB
Pharmacokinetics of furosemide in patien
β
G. GonzΓ‘lez; A. Arancibia; M. I. Rivas; P. Caro; C. Antezana
π
Article
π
1982
π
Springer
π
English
β 610 KB
Pharmacokinetics of zidovudine in patien
β
Taburet, Anne-Marie; Naveau, Sylvie; Zorza, GrΓ©goire; Colin, Jean-Noel; Delfrais
π
Article
π
1990
π
Nature Publishing Group
π
English
β 578 KB
Pharmacokinetics of diacerein in patient
β
O. Magnard; K. Louchahi; M. Tod; O. Petitjean; P. Molinier; L. Berdah; G. Perret
π
Article
π
1993
π
John Wiley and Sons
π
English
β 388 KB
π 1 views
The pharmacokinetics of diacerein following a single oral dose of 50 mg was studied in 12 healthy volunteers, 10 patients with a mild liver cirrhosis (Child Pugh's grade A), and 6 patients with a more severe liver cirrhosis (Child Pugh's grade B to C). Statistical analysis using a Kruskal-Wallis tes
Pharmacokinetics of metoclopramide in pa
β
E. Magueur; H. Hagege; P. Attali; E. Singlas; JP Etienne; AM Taburet
π
Article
π
1991
π
John Wiley and Sons
π
English
β 602 KB